Trial intelligence / Profile preview

Hyperbaric versus isobaric bupivacaine for spinal anesthesia in elective cesarean section

PACTR202205836867776Phase 4Not yet recruiting

Sponsor
Dilla University
Start
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of bupivacaine in Not applicable (2 arms), sponsored by Dilla University. Primary endpoints: Sensory block onset time, Motor block onset time and 2 more. Planned start Jun 2022; status: not yet recruiting.

02

Drugs

bupivacaine
03

Conditions

Not applicable

Beyond the preview

Go deeper on PACTR202205836867776.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202205836867776.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call